Acceleron Pharma Inc.
Methods for increasing red blood cell levels and treating ineffective erythropoiesis
Last updated:
Abstract:
In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in a subject in need thereof. Subjects in need include, for example, subjects having anemia and/or ineffective erythropoiesis as a result of having reduced GATA-1, heat shock factor and/or NFE2 levels as compared to the levels in a reference population.
Status:
Grant
Type:
Utility
Filling date:
4 Nov 2016
Issue date:
21 Sep 2021